BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4862314)

  • 1. [Experiences with the cytostatic podophyllin therapy].
    Halama J
    Munch Med Wochenschr; 1967 Feb; 108(7):378-81. PubMed ID: 4862314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Internal treatment of carcinoma with the cytostatic Proresid].
    Schärtl W
    Munch Med Wochenschr; 1966 Jan; 108(2):112-4. PubMed ID: 5341497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effects of podophyllin derivatives on malignant neoplasms].
    Diefenthaeler E; Herter NT
    Hospital (Rio J); 1968 Jan; 73(1):183-95. PubMed ID: 5308491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combines cytostatic treatment of malignant tumors. (Clinical histological report of 4 cases)].
    Busch W; Goldschmidt F
    Krebsarzt; 1967; 22(4):224-33. PubMed ID: 5592995
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the value of chloroquine in the treatment of malignant tumor diseases].
    Tanneberger S; Bacigalupo G
    Arch Geschwulstforsch; 1967; 29(3):266-73. PubMed ID: 4299158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Lipozencić M; Padovan I
    Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
    Br Med J; 1972 Jun; 2(5816):744-8. PubMed ID: 4556544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms].
    Varianti G
    Cancro; 1965; 18(6):526-41. PubMed ID: 4162232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with SP-I].
    Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)].
    Tomin R
    Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polychemotherapy of malignant tumors and hemoblastoses].
    Kühböck J; Pokorny D; Steinbach K; Eggerth G
    Wien Z Inn Med; 1968; 49(12):449-61. PubMed ID: 4311394
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vincaleukoblastine in the therapy of malignant neoplasms].
    Rotolo V
    Friuli Med; 1968; 23(1):31-52. PubMed ID: 4910040
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of Proresid on the growth and formation of metastases of the RBI-sarcoma in rats].
    Svec F; Altaner C
    Med Klin; 1968 Dec; 63(52):2119-25. PubMed ID: 5729222
    [No Abstract]   [Full Text] [Related]  

  • 15. [5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)].
    Hubacher O
    Dtsch Med Wochenschr; 1965 Nov; 90(48):2145-9. PubMed ID: 5844793
    [No Abstract]   [Full Text] [Related]  

  • 16. [New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo].
    Heckmann U
    Dtsch Med Wochenschr; 1967 May; 92(20):932-5 passim. PubMed ID: 4960735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
    Motti VJ
    Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of SPI, SPG and combination of radiotherapy in the management of certain tumors].
    Uzel R; Adali I; Civelekoğlu E
    Turk Tip Cemiy Mecm; 1967 Feb; 33(2):106-16. PubMed ID: 6040938
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
    Szántó L; Lörincz G; Gömör B
    Arzneimittelforschung; 1968 Jul; 18(7):886-9. PubMed ID: 5756046
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:154. PubMed ID: 5402573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.